- Home
- WAI vs BNR Comparison
WAI vs BNR Comparison
Compare WAI & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAI
- BNR
- Stock Information
- Founded
- WAI 2018
- BNR 2014
- Country
- WAI China
- BNR China
- Employees
- WAI N/A
- BNR N/A
- Industry
- WAI
- BNR Medical Specialities
- Sector
- WAI
- BNR Health Care
- Exchange
- WAI NYSE
- BNR Nasdaq
- Market Cap
- WAI 40.5M
- BNR 29.1M
- IPO Year
- WAI 2023
- BNR 2020
- Fundamental
- Price
- WAI $0.48
- BNR $4.22
- Analyst Decision
- WAI
- BNR
- Analyst Count
- WAI 0
- BNR 0
- Target Price
- WAI N/A
- BNR N/A
- AVG Volume (30 Days)
- WAI 1.8M
- BNR 29.7K
- Earning Date
- WAI 08-24-2025
- BNR 08-21-2025
- Dividend Yield
- WAI N/A
- BNR N/A
- EPS Growth
- WAI N/A
- BNR N/A
- EPS
- WAI N/A
- BNR N/A
- Revenue
- WAI $3,750,352.00
- BNR $72,112,038.00
- Revenue This Year
- WAI N/A
- BNR $136.32
- Revenue Next Year
- WAI N/A
- BNR N/A
- P/E Ratio
- WAI N/A
- BNR N/A
- Revenue Growth
- WAI N/A
- BNR 0.53
- 52 Week Low
- WAI $0.44
- BNR $2.18
- 52 Week High
- WAI $20.00
- BNR $7.90
- Technical
- Relative Strength Index (RSI)
- WAI N/A
- BNR 63.77
- Support Level
- WAI N/A
- BNR $3.06
- Resistance Level
- WAI N/A
- BNR $3.50
- Average True Range (ATR)
- WAI 0.00
- BNR 0.21
- MACD
- WAI 0.00
- BNR 0.05
- Stochastic Oscillator
- WAI 0.00
- BNR 95.65
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides some essential business services in China to young and emerging companies, including corporate business training services, which mainly focus on knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising; and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.